These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31541141)

  • 1. Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats.
    Das M; Mayilsamy K; Tang X; Han JY; Foran E; Willing AE; Mohapatra SS; Mohapatra S
    Sci Rep; 2019 Sep; 9(1):13646. PubMed ID: 31541141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with shCCL20-CCR6 nanodendriplexes and human mesenchymal stem cell therapy improves pathology in mice with repeated traumatic brain injury.
    Mayilsamy K; Markoutsa E; Das M; Chopade P; Puro D; Kumar A; Gulick D; Willing AE; Mohapatra SS; Mohapatra S
    Nanomedicine; 2020 Oct; 29():102247. PubMed ID: 32599163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury.
    Darkazalli A; Ismail AA; Abad N; Grant SC; Levenson CW
    Restor Neurol Neurosci; 2016 Apr; 34(3):433-41. PubMed ID: 27080073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury.
    Sasaki M; Radtke C; Tan AM; Zhao P; Hamada H; Houkin K; Honmou O; Kocsis JD
    J Neurosci; 2009 Nov; 29(47):14932-41. PubMed ID: 19940189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of parietal cytokine and chemokine gene profiles by mesenchymal stem cell as a basis for neurotrauma recovery.
    Lin CH; Lin W; Su YC; Cheng-Yo Hsuan Y; Chen YC; Chang CP; Chou W; Lin KC
    J Formos Med Assoc; 2019 Dec; 118(12):1661-1673. PubMed ID: 30709695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of human mesenchymal stem cells on traumatic brain injury in rats: secretion of neurotrophic factors and inhibition of apoptosis.
    Kim HJ; Lee JH; Kim SH
    J Neurotrauma; 2010 Jan; 27(1):131-8. PubMed ID: 19508155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury.
    Hu J; Chen L; Huang X; Wu K; Ding S; Wang W; Wang B; Smith C; Ren C; Ni H; ZhuGe Q; Yang J
    Stem Cell Res Ther; 2019 Mar; 10(1):96. PubMed ID: 30876457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of human chorionic membrane mesenchymal stem cells promotes functional recovery in a rat traumatic brain injury model.
    Zhou H; Yi Z; Le D; Mao G; Zhang H
    Neuroreport; 2024 Feb; 35(2):81-89. PubMed ID: 38109419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Promising Effects of Transplanted Umbilical Cord Mesenchymal Stem Cells on the Treatment in Traumatic Brain Injury.
    Qi L; Xue X; Sun J; Wu Q; Wang H; Guo Y; Sun B
    J Craniofac Surg; 2018 Oct; 29(7):1689-1692. PubMed ID: 30234712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinforced-hydrogel encapsulated hMSCs towards brain injury treatment by trans-septal approach.
    Sultan MT; Choi BY; Ajiteru O; Hong DK; Lee SM; Kim HJ; Ryu JS; Lee JS; Hong H; Lee YJ; Lee H; Suh YJ; Lee OJ; Kim SH; Suh SW; Park CH
    Biomaterials; 2021 Jan; 266():120413. PubMed ID: 33038593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury.
    Zhang Y; Chopp M; Zhang ZG; Katakowski M; Xin H; Qu C; Ali M; Mahmood A; Xiong Y
    Neurochem Int; 2017 Dec; 111():69-81. PubMed ID: 27539657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model.
    Park HJ; Shin JY; Lee BR; Kim HO; Lee PH
    Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of RADA16-BDNF peptide scaffold with human umbilical cord mesenchymal stem cells forced with CXCR4 and activated astrocytes for repair of traumatic brain injury.
    Shi W; Huang CJ; Xu XD; Jin GH; Huang RQ; Huang JF; Chen YN; Ju SQ; Wang Y; Shi YW; Qin JB; Zhang YQ; Liu QQ; Wang XB; Zhang XH; Chen J
    Acta Biomater; 2016 Nov; 45():247-261. PubMed ID: 27592818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of mesenchymal stem cells genetically engineered to overexpress interleukin-10 promotes alternative inflammatory response in rat model of traumatic brain injury.
    Peruzzaro ST; Andrews MMM; Al-Gharaibeh A; Pupiec O; Resk M; Story D; Maiti P; Rossignol J; Dunbar GL
    J Neuroinflammation; 2019 Jan; 16(1):2. PubMed ID: 30611291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
    Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
    Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.
    Willing AE; Das M; Howell M; Mohapatra SS; Mohapatra S
    CNS Neurosci Ther; 2020 Jun; 26(6):616-627. PubMed ID: 32157822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with Treg and mesenchymal stromal cells enhances potency and attenuation of inflammation after traumatic brain injury compared to monotherapy.
    Caplan HW; Prabhakara KS; Toledano Furman NE; Zorofchian S; Kumar A; Martin C; Xue H; Olson SD; Cox CS
    Stem Cells; 2021 Mar; 39(3):358-370. PubMed ID: 33368792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury.
    Ma H; Lam PK; Tong CSW; Lo KKY; Wong GKC; Poon WS
    Cell Transplant; 2019 Jul; 28(7):874-884. PubMed ID: 31185737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.